These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9723413)

  • 1. Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia.
    Kohnle M; Lütkes P; Witzke O; Philipp T; Heemann U
    Transplant Proc; 1998 Aug; 30(5):2122-3. PubMed ID: 9723413
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia.
    Kohnle M; Lütkes P; Zimmermann U; Philipp T; Heemann U
    Transplant Proc; 1999 Nov; 31(7A):44S-45S. PubMed ID: 10576043
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients.
    Burrows L; Knight R; Genyk Y; Schwartz B; Moran V; Anand R
    Transplant Proc; 1998 Aug; 30(5):2030-2. PubMed ID: 9723378
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.
    Rostaing L; Sánchez-Fructuoso A; Franco A; Glyda M; Kuypers DR; Jaray J
    Transpl Int; 2012 Apr; 25(4):391-400. PubMed ID: 22211928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
    Busque S; Demers P; Saint-Louis G; Boily JG; Tousignant J; Lemieux F; Martin G; Smeesters C; Corman J; Daloze P
    Ann Chir; 1999; 53(8):687-9. PubMed ID: 10584376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study.
    Morgan JD; Swarbrick MJ; Edwards CM; Donnelly PK
    Transpl Int; 1994; 7 Suppl 1():S320-1. PubMed ID: 11271240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid resolution of gingival hyperplasia after switching from cyclosporine A to tacrolimus.
    Dodd DA
    J Heart Lung Transplant; 1997 May; 16(5):579. PubMed ID: 9171281
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
    Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
    Oellerich M; Armstrong VW; Schütz E; Shaw LM
    Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 13. High QT dispersion in tacrolimus-treated kidney transplant recipients.
    Gerhardt U; Suwelack B; Pawolka A; Hohage H
    Transplant Proc; 2001 May; 33(3):2148-50. PubMed ID: 11377482
    [No Abstract]   [Full Text] [Related]  

  • 14. Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.
    Fernando ON; Sweny P; Varghese Z
    Transplant Proc; 1998 Jun; 30(4):1243-4. PubMed ID: 9636505
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
    Zadrazil J; Horak P; Zahalkova J; Strebl P; Horcicka V; Krejci K; Bachleda P; Dedochova J; Valkovsky I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):67-73. PubMed ID: 19365530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
    Margreiter R; Pohanka E; Sparacino V; Sperschneider H; Kunzendorf U; Huber W; Lameire N; Andreucci VE; Donati D; Heemann U;
    Transpl Int; 2005 Jul; 18(7):816-23. PubMed ID: 15948861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete response to tacrolimus in a child with severe aplastic anemia resistant to cyclosporin A.
    Macartney C; Freilich M; Odame I; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2009 Apr; 52(4):525-7. PubMed ID: 19058202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
    Colak T; Karakayali H; Yagmurdur MC; Moray G
    Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Hené RJ; Blom HJ; Demacker PN; Hilbrands LB
    Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient.
    Bader G; Lejeune S; Messner M
    J Periodontol; 1998 Jun; 69(6):729-32. PubMed ID: 9660343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.